NCT06014138 - Volatile Sedation for Patients With the Acute Respiratory Distress Syndrome | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

March 31, 2025

Conditions

Acute Respiratory Distress SyndromeMechanical Ventilation ComplicationSedation Complication

Interventions

DRUG

Propofol

Standard care, propofol sedation - 2 hour periods of observation before and after inhaled volatile sedation

DRUG

Isoflurane

Inhaled volatile sedation for 6 hours - 2 hours wash in / wash out, followed by 4 hours of observations

Trial Locations (1)

RECRUITING

Guy's & St Thomas' NHS Foundation Trust, London